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 BACKGROUND 
 Tumours originating from the heart are a rarity with a 
reported incidence between 0.0017 and 2.8% in various 
autopsy series. 1 – 4 Most are true neoplasms, albeit benign, 
with myxomas accounting for more than half of these. 1  3  5 –
 9 Myxomas are usually solitary and the most frequent site 
for a myxoma is the left atrium. 3  4  10–11 Systemic embolisa-
tion is a common complication with the brain harbouring 
majority of these metastases. 4  6  9  12  13 The intracranial man-
ifestations observed include embolic infarcts, aneurysms, 
central nervous system (CNS) lesions and haemorrhage. 
Complete surgical resection is often curative in those with 
intracardiac disease alone. Although recurrence is rare, it is 
usually seen after embolisation of primary tumour, after an 
incomplete resection or in familial cases. 8  9  14 – 16 
 We report a case of a middle-aged female who devel-
oped non-aneurysmal, non-myxomatous intraparenchy-
mal haemorrhagic sequelae following successful resection 
of her atrial myxoma. 
 We feel this is important to report for the following rea-
sons: the patient did not have aneurysms and yet developed 
multi-focal CNS haemorrhage. Additionally, no malignant 
myxomatous features were reported on the histopathology 
of her CNS lesion after resection and yet she demonstrated 
repeated worsening of intracranial haemorrhage (ICH) in a 
naturally malignant course (ﬁ gure 1). 
 CASE PRESENTATION 
 A 47-year-old previously healthy lady ﬁ rst presented to the 
emergency room in October 2010 with a new-onset chest 
pain along with dyspnoea and associated with off and on 
low-grade fever for the last 4 weeks. On examination, she 
was a middle-aged lady with average height and built, afe-
brile but with a mild tachypnoea. She was neurologically 
intact. 
 On initial presentation, the erythrocyte sedimenta-
tion rate was 38. Her arterial blood gases, urea and elec-
trolytes, coagulation proﬁ le and liver function tests were 
unremarkable. Her chest x-ray did not reveal any abnor-
mality. No neuroimaging was done at this stage as it was 
unwarranted. 
 A transthoracic echocardiogram (TTE) revealed a mobile, 
pedunculated, echogenic mass in the left atrium attached 
to the intra-atrial septum, 6×3×4 cm in size and causing 
mitral inﬂ ow obstruction. She then underwent surgical 
resection of the mass. She went home 5 days later in a 
stable condition. A postoperative TTE showed no residual 
mass. The ﬁ nal histopathology report revealed the mass to 
be a benign atrial myxoma. 
 Four months after this surgery, the patient presented 
in the emergency department in generalised tonic-clonic 
status epilepticus. A MRI of her brain revealed multiple 
hyper-intense lesions with surrounding oedema in the 
cerebellar and cerebral hemispheres bilaterally with no 
postcontrast enhancement. However, her repeat echocar-
diogram showed no new or residual atrial mass. A cere-
bral CT angiography was negative for presence of arterial 
aneurysms. 
 She was conservatively managed with phenytoin for her 
seizures and discharged. Two months later, she was again 
admitted through emergency for breakthrough seizures 
and drowsiness of 1 day. A cranial MRI done this time re-
demonstrated multiple haemorrhagic lesions in the brain 
which had increased in number and size. The largest, in 
the left occipital lobe, measured 22.7×17.1 mm. There was 
also subtle postcontrast enhancement seen now. A conven-
tional cerebral angiogram done to evaluate the intracranial 
vasculature again was normal (ﬁ gure 2). Her echocardio-
gram was also negative for recurrence. A CAT scan of her 
chest, abdomen and pelvis revealed no metastatic disease. 
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 She got a neurosurgical evaluation. Lamotrigine was 
added to her antiepileptic regimen. She was discharged 
when her serum valproate and phenytoin levels were 
within desirable range. 
 Although her seizures were controlled on the new 
regimen, in 2 months’ time, she was readmitted with pro-
gressive right-sided weakness, drowsiness and visual dis-
turbance. Neurological examination revealed a visual ﬁ eld 
defect, papilloedema and a 4/5 motor power in the right 
extremities and alexia without agraphia. 
 To evaluate the status of her brain, an MRI was repeated 
which showed a growing contrast-enhancing, space-occu-
pying left occipital haemorrhagic lesion, measuring 5.4×2.3 
cm and causing a midline shift. 
 She underwent a craniotomy and excision of this lesion 
and her status improved subsequently. The histology of 
the lesion was not consistent with that of atrial myxoma 
and it was reported as a haemorrhagic infarct. There were 
no inﬂ ammatory cells in the lesion. 
 She left home stable, with a visual ﬁ eld deﬁ cit, subtle 
memory difﬁ culties and complete recovery of her right 
hemiparesis. 
 Three months after her craniotomy, she was brought in 
with complaints of drowsiness, headache and vomiting. 
She was unable to walk and had developed central ataxia. 
A cerebral MRI redemonstrated multiple cerebral and cer-
ebellar haemorrhagic lesions, with the latter having grown 
considerably since previous imaging. Neurosurgical evalu-
ation was done, however given the size and multiplicity of 
lesions, she was declared unﬁ t for surgery. As a desperate 
measure to reduce the intensity of her bleeding, in addition 
to steroids, a short course of mannitol and symptomatic 
therapy, she was also given oral tranexamic acid at 500 mg 
four times a day for 3 days. 
 Within 24 h of administration, she became better. Her 
vomiting and drowsiness improved. She became able to 
walk with assistance and her mannitol was successfully 
tapered off. At this point, despite no change in her lesion 
status, she is at home with resumption of her daily activi-
ties and remains on a low dose of steroids (dexamethasone 
2 mg daily). 
 OUTCOME AND FOLLOW-UP 
 At this point in writing, the patient remains stable with 
steroids and is seeking radiotherapy opinion given this 
review. 
 DISCUSSION 
 When symptomatic, atrial myxomas have obstructive, 
metastatic and/or constitutional manifestations and most 
frequently present with dyspnoea signifying some degree 
of heart failure. 5  9  13  17 Left atrial myxomas have a propen-
sity to embolise haematogenously and get deposited in the 
brain, bone, cartilage, skin, abdominal organs and soft tis-
sues. 6  9  13 Benign atrial myxomas are usually sporadic with 
less than one-ﬁ fth of the cases being familial as reported in 
literature. 3 Although rare, these familial cases tend to pose 
a bigger challenge because they are often multiple, have 
variable resistance to treatment, a higher risk of recurrence 
and early age at presentation. 3  14  15 
 Figure 1  Serial neuroimaging showing expanding intracranial haemorrhage. 
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 Familial syndromes with atrial myxomas include naevi, 
atrial myxoma, myxoid neuroﬁ bromata and ephelides, len-
tigines, atrial myxoma, mucocutaneous myxoma, and blue 
naevi and the autosomal dominant Carney’s syndrome. 
In cases where these are suspected due to presentation, 
the family can be screened with TTE or genetic testing 
depending upon availability. 
 Neurologic manifestations of atrial myxoma are com-
mon and include ischaemic events with myxomatous 
fragments occluding or stenosing the small calibre intra-
cerebral vasculature. 18  19 This embolisation may occur 
as part of the natural history or may be iatrogenic when 
during resection and removal, a fragment dislodges. 8 
Moreover, although less common, arterial wall weakness 
has also been described and is associated with both myxo-
matous and non-myxomatous aneurysm formation, often 
years after resection of the primary tumour. 4  6  9  13  18  19 
Even less often seen are the haemorrhagic sequelae, both 
intraparenchymal and subarachnoid bleeds subsequent to 
rupture of these aneurysms. 4 True metastasis and prolif-
eration of extra-arterial myxomatous tissue is a rare phe-
nomenon, at best. 9  13 
 The age, sex, location and initial presentation of atrial 
myxoma in our patient correspond to that described in lit-
erature (table 1). 3 – 5  9  11  13  17  20 However, she represents a rare 
case where she had recurrent large cerebral parenchymal 
haemorrhages mainly in the vertebrobasilar territory but also 
involving the anterior circulation without any histological 
evidence of myxomatous features in the lesions or any angi-
ographic evidence of aneurysm in intracranial vessels. There 
is paucity of data regarding this rare phenomenon. 13  18  21 
 Intracranial haemorrhages occur secondary to aneurysm 
formation. 10  20 If and how often will non-aneurysmal 
arteries bleed into the parenchyma cannot be predicted. 22 
Knepper et al have, in their series, reported one case of sub-
arachnoid haemorrhage where the haemorrhage occurred 
without angiographic evidence of aneurysms. 13 We pos-
tulate that silent tumour embolisation occurred during 
surgery and then manifested later with seizures and devel-
opment space occupying lesion. This seems more probable 
especially due to the fact that there was signiﬁ cant load of 
lesions in the territory of posterior circulation. 23  24 
 The time from diagnosis of atrial myxoma to the appear-
ance of intracranial aneurysms is also variable. 4 Should 
 Figure 2  Four-vessel cerebral angiogram showing absence of aneurysms and vasculitis. 
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serial cerebral angiography be done for detection is still a 
matter of debate since the treatment modalities for these 
aneurysms, whether aneurysmectomy or chemotherapy 
with doxorubicin, have yielded inconclusive results. 4  10 
 The treatment of spontaneous intraparenchymal bleed 
remains supportive and preventive. 25 There are no guide-
lines speciﬁ c for bleeds due to atrial myxomas. 1 In our 
patient after surgical excision of the largest haemorrhagic 
lesion, tranexamic acid was started to prevent rebleeding. 
Although there is literature to support the use of tran-
examic acid in patients with berry aneurysms and sub-
arachnoid haemorrhage, 26  27 we have employed the same 
in the hope of preventing further episodes of non-aneurys-
mal intra-parenchymal haemorrhage at least as a temporis-
ing measure. 28 It has been 2 months since the initiation of 
this therapy with no new episode of parenchymal bleed, 
although it is premature to predict future risk. How long 
will the antiﬁ brinolytic effect of the 3-day course of tran-
examic acid last can also not be predicted. In addition, it 
cannot be ruled out that the effects of tranexamic acid was 
due to chance, improving natural history or the use of con-
current medications to lower intracranial pressure. 
 The possibility of a concomitant disease like vasculitis 
cannot entirely be ruled out, although the absence of stroke 
and the expanding nature of each ICH over time, argues 
against this theory. We were unable to ﬁ nd evidence of 
inﬂ ammatory cells in the resection lesion at biopsy which 
further refutes this possibility although does not eliminate 
it entirely. 
 In patients with intraparenchymal manifestations of 
atrial myxoma, there are only four reported cases that 
received brain radiation. 1  8  29  30 Most recently, Moiyadi 
 et al described a patient who received 25Gy focal radia-
tion following craniotomy and excision of lesion with no 
residual neurological deﬁ cit post treatment. 30 Altundag  et al 
have also reported a case where a patient received 30 Gy 
whole brain radiation for an embolised benign myxoma. 
Previously, Bernet  et al reported a patient who received 
5000 Gy whole brain radiation along with chemotherapy 
for myxomatous metastases with malignant features to 
the brain and elsewhere; resolution of these lesions was 
seen following treatment. The earliest report we could 
ﬁ nd was by Todo  et al where a patient received 60Gy of 
radiation for brain lesion. This patient, however, died of 
cerebral herniation due to enlarging intracranial masses 
within a year of treatment. 29 We are now contemplating 
radiation in our case; however, our patient’s histopathol-
ogy of haemorrhagic infarct taken from the occipital loca-
tion does not necessarily correlate with the intervention in 
the literature. 
 FUTURE DIRECTIONS 
 It has been hypothesised that interleukin-6 may be respon-
sible for the metastasising nature of the otherwise benign 
cardiac myxomas. 31 This is an area which can be looked at 
in future. When atrial myxomas are associated with intrac-
ranial haemorrhage, further research is needed into haemo-
static therapy, safety of surgery and irradiation especially 
when aneurysms and malignant potential are not found as 
in this case. 
 Learning points 
 ▶  Atrial myxomas are the commonest cardiac tumours 
with neurologic complications being the most frequent 
extra-cardiac manifestations; familial atrial myxoma 
syndromes exist. 
 The neurological sequelae include embolic infarcts,  ▶
aneurysms, intracranial bleed and space-occupying 
lesions; in that order of frequency/ 
 As in the described case, although rare, there may  ▶
be large intraparenchymal bleeds requiring excision, 
without angiographic evidence of aneurysms. 
 Whole brain radiation may have a role in preventing  ▶
rebleeding and reducing the size of existing lesions 
and the literature describes this for both benign and 
malignant pathology. 
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